Delivery Order SPE2DB22D1052-SPE2DB25FU9KL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,602.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,504.92 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Jardiance 10 mg tablets (90-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is to be fulfilled at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $40,271.47 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 4, 2025, with completion due by August 5, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $62,545.34 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract, issued without set-aside designation, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $1,571.08. This contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The award was made through open competition with no set-aside designation. Performance...
- The Defense Logistics Agency has awarded a delivery order valued at $18,417.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $55,053.97 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9KLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,354.81 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical procurement landscape, particularly supporting military and veteran healthcare systems. As a major pharmaceutical distributor, the company supplies a comprehensive portfolio of brand-name and generic medications across multiple therapeutic domains through its DLA prime contract vehicle, which enables global pharmaceutical support for military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The current order for Jardiance, a diabetes management medication, reflects the company's consistent capability to fulfill federal medical supply requirements through open competition on a delivery order basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 6/16/25 |